Complications of cancer therapy in children: A radiologist's guide

被引:22
作者
Parisi, MT
Fahmy, JL
Kaminsky, CK
Malogolowkin, MH
机构
[1] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA
[3] Univ So Calif, Sch Med, Los Angeles, CA 90089 USA
[4] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA
关键词
chemotherapy; complications; radiations; injurious effects; complications of therapeutic radiology; neoplastic; therapeutic radiology; in infants and children;
D O I
10.1148/radiographics.19.2.g99mr05283
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
As advances in cancer therapy improve the prognosis of patients with childhood malignancies, awareness of the consequences of treatment methods assumes increasing importance. All cancer treatment modalities are associated with toxic effects, and the spectrum of therapy-induced complications involves all organ systems. Radiologists have a pivotal role in detecting these sequelae, which can be categorized by the affected organ system and by whether they occur (a) at diagnosis or during initial therapy or (b) after the completion of treatment. The first group consists of oncologic emergencies, infectious complications, and irritant effects. Oncologic emergencies can be further categorized as space-occupying lesions (eg, superior vena cava syndrome or spinal cord compression), vascular abnormalities (eg, hyperleukocytosis, anemia, coagulopathy), and metabolic emergencies (eg, tumor lysis syndrome). Common complications developing after completion of treatment include leukoencephalopathy and neurocognitive defects; cataract formation; cardiomyopathy and congestive heart failure; hepatic dysfunction, fibrosis, and cirrhosis; radiation enteritis; renal dysfunction or failure; scoliosis and short stature; hypothyroidism; gonadal dysfunction; graft-versus-host disease; and development of secondary malignancies. Physician awareness of these complications will permit more effective patient surveillance, which may afford patients the opportunity for earlier intervention in these situations and improved quality of life.
引用
收藏
页码:283 / 297
页数:15
相关论文
共 53 条
[1]  
ALBANO EA, 1988, PEDIATR CLIN N AM, V35, P873
[2]  
ALLEGRETTA GJ, 1985, PEDIATR CLIN N AM, V32, P613
[3]  
ALLEGRETTA GJ, 1985, PEDIATR CLIN N AM, V32, P601
[4]   Breast cancer and other second neoplasms after childhood Hodgkin's disease [J].
Bhatia, S ;
Robison, LL ;
Oberlin, O ;
Greenberg, M ;
Bunin, G ;
FossatiBellani, F ;
Meadows, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :745-751
[5]   INFECTIONS DURING INTENSIVE CHEMOTHERAPY FOR NON-HODGKIN LYMPHOMA [J].
BISHOP, JF ;
SCHIMPFF, SC ;
DIGGS, CH ;
WIERNIK, PH .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (05) :549-555
[6]  
BLEYER WA, 1981, CANCER TREAT REP, V65, P89
[7]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[8]   NEUTROPENIA, FEVER, AND INFECTION [J].
BROWN, AE .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (03) :421-428
[9]  
BYRD R, 1985, PEDIATR CLIN N AM, V32, P835
[10]  
Chen CY, 1996, AM J NEURORADIOL, V17, P295